Detalhe da pesquisa
1.
Assessing the impact of prophylactic anidulafungin during remission induction of acute myeloid leukemia - A propensity-score matching analysis.
J Mycol Med
; 33(4): 101434, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683564
2.
Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience.
Clinics (Sao Paulo)
; 75: e1566, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294670
3.
Renal infiltration presenting as acute kidney injury in Hodgkin lymphoma - A case report and review of the literature.
Leuk Res Rep
; 10: 41-43, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30225192
4.
Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience
Clinics
; 75: e1566, 2020. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1101081
5.
Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin.
Hematol Transfus Cell Ther
; 41(4): 356-359, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582343
6.
Current role of interferon in hairy cell leukemia therapy: a timely decision.
Hematol Transfus Cell Ther
; 41(1): 88-90, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793110
7.
Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin
Hematol., Transfus. Cell Ther. (Impr.)
; 41(4): 356-359, Oct.-Dec. 2019. ilus
Artigo
em Inglês
| LILACS | ID: biblio-1056239